High-affinity rabbit anti-ID Abs serve as essential capture and detection reagents in ELISA-based assays to precisely quantify therapeutic antibody concentrations in biological samples, determining free, total, or target-bound drug levels.
Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsCreative Biolabs delivers premier rabbit anti-idiotypic antibody production services, leveraging cutting-edge technology and profound immunological expertise. We have established a world-leading platform for the selection, production, and engineering of rabbit anti-idiotypic antibodies (anti-ID Abs). Our scientists have successfully generated high-quality rabbit anti-ID Abs against numerous therapeutic antibodies. Besides, we offer the development of both polyclonal and monoclonal rabbit anti-ID Abs.
Anti-ID Abs are specialized antibodies that recognize the unique variable region (idiotype) of another antibody, such as a therapeutic antibody. This highly specific interaction renders them indispensable tools in drug development, enabling precise detection and quantification of antibody drugs or the immune response they elicit.
Rabbits stand out as a superior host for generating anti-ID Abs due to their distinct immunological advantages. Their immune system often produces antibodies with higher affinity and broader epitope recognition compared to rodents, which is crucial for developing sensitive assays. This capability extends to recognizing novel epitopes on human or humanized therapeutic antibodies that might be poorly immunogenic in other species. While rabbit antibodies possess unique structural features, such as specific glycan patterns on the Fc region and an additional disulfide bridge in the light chain variable region (VL-VC), our deep understanding of rabbit immunology and advanced protein engineering techniques ensures these characteristics are expertly managed. This results in highly functional and well-characterized reagents. For long-term studies requiring utmost consistency under validated conditions, monoclonal rabbit anti-ID Abs are typically the preferred choice, offering a renewable and homogenous supply.
High Specificity: Rabbit immune systems employ a dual positive- and negative-feedback screening mechanism, leading to higher specificity and reduced non-specific interference compared to mouse monoclonal antibodies.
Broad Diversity: The rabbit immune system facilitates the generation of a more diverse array of antibodies, including a greater capacity for both inhibitory and non-inhibitory anti-ID Abs.
Expanded Epitope Recognition: Rabbits can mount immune responses against a wider range of antigens, including epitopes often missed by mouse antibodies, particularly small molecules or post-translational modification targets.
Superior Affinity: Rabbit monoclonal antibodies exhibit 10-100 times higher affinity than mouse antibodies, enhancing sensitivity for detecting monoclonal antibody drugs in biological samples.
Enhanced Manufacturing Efficiency: The larger spleen and higher B cell content in rabbits enable the production of greater antibody quantities per production cycle, thereby improving the efficiency of monoclonal antibody generation through high-throughput screening.
Creative Biolabs offers a comprehensive rabbit anti-ID Ab discovery service, encompassing both polyclonal and monoclonal development pathways. Our process begins with strategic consultation and immunogen design, tailored to your specific therapeutic antibody and assay requirements. We employ optimized immunization protocols in rabbits, followed by meticulous immune response monitoring. For monoclonal antibody generation, we utilize our advanced B-cell Discovery Platform, which combines efficient B-cell sorting with high-throughput screening to isolate rare clones producing high-affinity, highly specific anti-ID Abs. Our services cover everything from initial antigen strategy to the delivery of fully characterized, assay-ready antibodies, including blocking, non-blocking, and complex-specific variants.
High-affinity rabbit anti-ID Abs serve as essential capture and detection reagents in ELISA-based assays to precisely quantify therapeutic antibody concentrations in biological samples, determining free, total, or target-bound drug levels.
Polyclonal rabbit anti-ID Abs are excellent positive controls for anti-drug antibody assays. Monoclonal rabbit anti-ID Abs, particularly blocking types, are vital for developing assays to detect and characterize neutralizing antibodies (NAbs).
Rabbit anti-ID Abs are instrumental in comparative analytical studies to demonstrate the PK and immunogenic similarity between a biosimilar candidate and its reference product.
For therapies involving viral vectors or antibody-based targeting moieties, rabbit anti-ID Abs can help monitor vector immunogenicity or the persistence of antibody-based components.
Distributed under Unsplash License, from Unsplash.
Anti-idiotypic antibodies targeting antibodies against retinol-binding protein (RBP) and insulin have demonstrated specificity for the antigen-binding sites of their respective immunogens. Some rabbit anti-idiotypic antibodies against RBP antibodies bind selectively to rat intestinal epithelial cells, which house a cell-surface receptor for RBP facilitating retinol uptake. Remarkably, these antibodies impeded this uptake by competing with RBP. Similarly, antibodies against insulin antibodies hindered the binding of iodine-125 labeled insulin to rat fat cells and simulated insulin's action by encouraging α-aminoisobutyric acid uptake in rat thymocytes. Such findings highlight anti-idiotypic antibodies as potential instruments for exploring cell-membrane receptor functionalities.
Leveraging rabbit immunology to generate anti-ID Abs with picomolar affinities and exquisite specificity, crucial for sensitive assays.
Expertise in developing blocking, non-blocking, and complex-specific anti-ID Abs to meet diverse assay needs.
Anti-ID Abs are thoroughly characterized for affinity, specificity, epitope binning, and matrix tolerance, ensuring they are assay-ready.
Dedicated scientific support from project initiation to post-delivery, ensuring seamless integration into your workflows.
Creative Biolabs specializes in the tailored development of various anti-idiotypic antibodies to complement your therapeutic antibodies. Click here to explore our bespoke Anti-Idiotypic Antibodies Production Services designed to cater to your specific needs.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
